Biology and Treatment of Myelodysplasia
Einstein/Montefiore Department of Medicine Grand Rounds
Thursday, February 28, 2013
8:00 AM: Forchheimer Medical Science Building 3rd Fl Lecture Hall
Speaker & Info
Gary J. Schiller, M.D.
Professor in Residence, UCLA School of Medicine
Chair, Jonsson Comprehensive Cancer Center
Director, Hematological Malignancy Stem Cell Transplant Program
UCLA Ronald Reagan Medical Center
Repeated at 12:15 pm, Cherkasky Auditorium, Montefiore Medical Center
Dr. Gary J. Schiller is the author of over 100 peer-reviewed articles and has given nearly 300 presentations on hematological malignancies, bone marrow transplantation, and related elements of medicine. He has received several honors and rewards such as the Dean’s Award for Excellence in Education in 2001 and the Outstanding Tutor Award in 2007, 2009, and 2010 (all from the David Geffen UCLA School of Medicine). He holds memberships with several institutions including the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, the American Medical Association, the American Society for Blood and Marrow Transplantation, and the California Medical Association.
Dr. Schiller's research projects include clinical studies of new drugs, therapies and bone marrow transplantation for patients with malignancies of the blood or bone marrow such as leukemia, multiple myeloma, and lymphoma.
Dr. Schiller completed his medical education at the University of Southern California, his internal medicine residency and his fellowship in hematology and oncology at the UCLA School of Medicine. He has been practicing clinical medicine at UCLA since 1990. He became an Associate Professor of Medicine at the UCLA School of Medicine before becoming a Professor in Residence in 2004. He has been serving as a Chair for the Jonsson Comprehensive Cancer Center since 2003, and in 2007 he became the Director of the Hematological Malignancy Stem Cell Transplant Program at UCLA’s Ronald Reagan Medical Center.
After attending this activity, participants will be able to:
- Understand the clonal nature of myelodysplasia
- Repeat some of the prognostic criteria for survival
- Differentiate supportive vs. remittive vs. curative therapies for myelodysplasia
Accreditation: Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Division of Hematology (Department of Medicine)